# GeneDx
> GeneDx is a clinical genomics company specializing in advanced genetic testing for rare and complex diseases. Utilizing a dataset of nearly 1 million exomes and genomes, the company provides whole exome and whole genome sequencing services to pediatric providers, health systems, and biopharmaceutical partners.
- URL: https://optimly.ai/brand/genedx
- Slug: genedx
- BAI Score: 88/100
- Archetype: Challenger
- Category: Biotechnology
- Last Analyzed: April 10, 2026
## Competitors
- Invitae (https://optimly.ai/brand/invitae)
- Myriad Genetics, Inc. (https://optimly.ai/brand/myriad-genetics)
## Buyer Intent Signals
Problems: Symptom-based Clinical Diagnosis: Physicians manually comparing patient symptoms against medical literature and databases like OMIM without sequencing. | In-house Hospital Labs: Academic medical centers or children's hospitals using in-house sequencing labs and bioinformaticians.
Solutions: whole exome sequencing for rare disease | pediatric genetic testing labs | clinical genome sequencing providers | best genetic testing for newborns | biopharma genomic data partners | at-home medical DNA test for rare conditions | Standard Targeted Panels: Standard genetic panels that only look at a subset of genes (e.g., 200-500) rather than the whole exome/genome.
---
## Full Details / RAG Data
### Overview
GeneDx is listed in the AI Directory.
GeneDx is a clinical genomics company specializing in advanced genetic testing for rare and complex diseases. Utilizing a dataset of nearly 1 million exomes and genomes, the company provides whole exome and whole genome sequencing services to pediatric providers, health systems, and biopharmaceutical partners.
### Metadata
| Field        | Value |
|--------------|-------|
| Name         | GeneDx |
| Slug         | genedx |
| URL          | https://optimly.ai/brand/genedx |
| BAI Score    | 88/100 |
| Archetype    | Challenger |
| Category     | Biotechnology |
| Last Analyzed | April 10, 2026 |
| Last Updated | 2026-05-01T22:26:30.041Z |
### Verified Facts
- Founded: 1990 (Originally founded within NIH, later commercialized)
- Headquarters: Stamford, Connecticut, USA
### Competitors
| Name | Profile |
|------|---------|
| Invitae | https://optimly.ai/brand/invitae |
| Myriad Genetics, Inc. | https://optimly.ai/brand/myriad-genetics |
### Buyer Intent Signals
#### Problems this brand solves
- Symptom-based Clinical Diagnosis: Physicians manually comparing patient symptoms against medical literature and databases like OMIM without sequencing.
- In-house Hospital Labs: Academic medical centers or children's hospitals using in-house sequencing labs and bioinformaticians.
#### Buyers search for
- whole exome sequencing for rare disease
- pediatric genetic testing labs
- clinical genome sequencing providers
- best genetic testing for newborns
- biopharma genomic data partners
- at-home medical DNA test for rare conditions
- Standard Targeted Panels: Standard genetic panels that only look at a subset of genes (e.g., 200-500) rather than the whole exome/genome.
### Links
- Canonical page: https://optimly.ai/brand/genedx
- JSON endpoint: /brand/genedx.json
- LLMs.txt: /brand/genedx/llms.txt